We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
201 hedge funds and large institutions have $430M invested in Revance Therapeutics, Inc. in 2024 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 40 increasing their positions, 55 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more capital invested
Capital invested by funds: $209M → $430M (+$221M)
65% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 43
16% more funds holding
Funds holding: 173 → 201 (+28)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less call options, than puts
Call options by funds: $4.42M | Put options by funds: $5.33M
27% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 55
Holders
201
Holders Change
+28
Holders Change %
+16.18%
% of All Funds
2.89%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
71
Increased
40
Reduced
55
Closed
43
Calls
$4.42M
Puts
$5.33M
Net Calls
-$909K
Net Calls Change
-$1.71M
Top Buyers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$20.8M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$20.7M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$15.6M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$12.4M |
| 5 |
WIC
Water Island Capital
New York
|
+$11.8M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$35.8M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$18.1M |
| 3 |
JP Morgan Chase
New York
|
-$14M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.1M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$9.84M |
